Emerging in the field of obesity management, retatrutide presents a distinct strategy. Unlike many current medications, retatrutide operates as a dual agonist, at once targeting both GLP-like peptide-1 (GLP-1) and https://violazyua751344.wssblogs.com/38550118/this-novel-retatrutide-this-glp-gip-receptor-agonist